Related Experiment Videos
Eicosanoids in hypoxic insult to neonatal rabbit bowel
S Dollberg1, R Udassin, T Ginat-Israeli
1Department of Pediatrics, Bikur Cholim Hospital, Jerusalem, Israel.
Journal of Pediatric Gastroenterology and Nutrition
|August 1, 1992
Summary
Hypoxia alters eicosanoid levels in the bowel, increasing leukotriene B4 (LTB4) and decreasing prostaglandin E2 (PGE2). This shift may contribute to inflammatory bowel diseases by promoting inflammation and reducing protection.
Area of Science:
- Biochemistry
- Gastroenterology
- Neonatal Research
Background:
- Eicosanoids, derived from arachidonic acid, are implicated in inflammatory bowel diseases.
- Understanding eicosanoid roles in hypoxic intestinal injury is crucial for neonatal care.
Purpose of the Study:
- To investigate the role of prostaglandin E2 (PGE2), leukotriene B4 (LTB4), and leukotriene C4D4E4 (LTC4D4E4) in a neonatal rabbit model of hypoxic intestinal insult.
Main Methods:
- Neonatal rabbits were subjected to hypoxic insult or served as controls.
- Levels of PGE2, LTB4, and LTC4D4E4 were quantified using radioimmunoassay.
- Arachidonic acid metabolism pathways were analyzed based on mediator levels.
Main Results:
- Hypoxia significantly decreased PGE2 levels (p < 0.02) and increased LTB4 levels (p < 0.03) in the intestine.
- No significant difference in LTC4D4E4 levels was observed between hypoxic and control groups.
- Hypoxia shifted arachidonic acid metabolism towards increased lipoxygenase activity and decreased cyclooxygenase activity.
Conclusions:
- Hypoxia alters intestinal eicosanoid profiles, favoring LTB4 production and reducing PGE2.
- This imbalance may enhance intestinal inflammation and diminish cytoprotection, contributing to ischemic-hypoxic bowel disease pathogenesis.
- Further research into eicosanoid modulation could offer therapeutic strategies for neonatal hypoxic enteropathy.